Gm2A Protein Gm2 Activator Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GM2A (GM2 Activator Protein) is a soluble lysosomal protein that plays an essential role in the degradation of GM2 ganglioside. It functions as a substrate-specific co-factor for hexosaminidase A, presenting GM2 ganglioside to the enzyme for hydrolysis.
Gm2A Protein Gm2 Activator Protein is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Overview
GM2A (GM2 Activator Protein) is a soluble lysosomal protein that plays an essential role in the degradation of GM2 ganglioside. It functions as a substrate-specific co-factor for hexosaminidase A, presenting GM2 ganglioside to the enzyme for hydrolysis.
Structure
GM2A is a small, soluble protein (~17.6 kDa) with a unique beta-sheet dominated fold that creates a hydrophobic cavity for lipid binding. The protein has:
Soluble structure suitable for lysosomal function
Lipid-binding pocket for GM2 ganglioside
Interface for interaction with hexosaminidase A
Normal Function
Lipid Catabolism
GM2A's primary function is to facilitate GM2 ganglioside degradation:
Binds GM2 ganglioside in the lysosomal lumen
Presents substrate to hexosaminidase A (Hex A)
Enables hydrolysis of GM2 to GM3
Prevents accumulation of toxic gangliosides
Lysosomal Homeostasis
Proper GM2A function ensures:
Neuronal membrane lipid composition
Lysosomal digestive capacity
Cellular lipid homeostasis
Role in Disease
GM2 Gangliosidosis (AB Variant)
GM2A mutations cause AB variant of GM2 gangliosidosis:
Accumulation of GM2 ganglioside in [neurons](/entities/neurons)
The study of Gm2A Protein Gm2 Activator Protein has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Unknown, Structure of GM2 activator protein (n.d.)](https://pubmed.ncbi.nlm.nih.gov/12445476/)
[Unknown, GM2 activator deficiency and disease (n.d.)](https://pubmed.ncbi.nlm.nih.gov/12510590/)